auto_awesome
Want to know who else bid on this?
Proposal Forge correlates this contract with the original RFP, the losing bidders, and the next recompete window.
Recipient
Galenvs Sciences Inc.Department
National Research Council CanadaAmount
$266.5K
Program
Innovative Solutions CanadaProvince
QCType
Grant
Agreement Number
172-2020-2021-Q2-955723
Purpose
COVID-19 Challenge: To develop a proof of concept for The National Research Council Canada (NRC) is seeking a solution for reagents required for nucleic acid sample preparation and rapid and efficient SARS-CoV-2 Ribonucleic Acid (RNA) extraction in order to perform downstream molecular diagnostics of COVID-19 with capability to integrate within existing and/or potential microfluidic platforms for sample-to-answer solutions that can be deployed on the frontline for rapid testing.
Galenvs Sciences Inc. × National Research Council Canada
9 grants totalling $2.2M
Innovative Solutions Canada
165 grants totalling $78.1M
Related Grants
| Recipient | Amount | Program |
|---|---|---|
| Nicoya Lifesciences Inc. | $2.0M | Innovative Solutions Canada |
| Deep Biologics Inc. | $2.0M | Innovative Solutions Canada |
| Plasmagear Inc. | $2.0M | Innovative Solutions Canada |
| Acuva Technologies Inc. | $2.0M | Innovative Solutions Canada |
| Braebon Medical Corporation | $2.0M | Innovative Solutions Canada |